Originator Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | IND Application | US | 17 Nov 2022 | |
Neoplasms | IND Application | US | 17 Nov 2022 | |
Neoplasms | IND Application | US | 17 Nov 2022 |